Difference between revisions of "LncRNAWiki:Glioma"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !width="50"|Name !width="50"|Transcript ID !width="50"|Alias !width="50"|Description !width="50"|Disease |-...") |
|||
| Line 60: | Line 60: | ||
|"downregulated RNA in cancer, inhibitor of cell invasion and migration" | |"downregulated RNA in cancer, inhibitor of cell invasion and migration" | ||
|prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | |prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma | ||
| + | |- | ||
| + | |''LINC01198'' | ||
| + | |[[LINC01198]] | ||
| + | |N/A | ||
| + | |long intergenic non-protein coding RNA 1198 | ||
| + | |anaplastic gliomas | ||
|} | |} | ||
Revision as of 07:14, 28 June 2017
| Name | Transcript ID | Alias | Description | Disease |
|---|---|---|---|---|
| CDKN2B-AS1 | NONHSAT130421,lnc-C9orf53-2:1 | "ANRIL, p15AS, ENSG00000240498" | CDKN2B antisense RNA 1 | glioma |
| H19 | NONHSAT017465 | Q96MK8,ENSG00000130600 | "H19, imprinted maternally expressed transcript (non-protein coding)" | "bladder cancer, breast cancer, cervical cancer, choricarcinoma, colon cancer, Congenital hyperinsulinism, Esophageal squamous cell cancer, gastric cancer, germ cell tumor, gestational choriocarcinoma, glioblastoma, glioma, growth restriction, hematopoiesis, infertility, kidney cancer, liver cancer, lung cancer, Marek's disease, Medulloblastoma, melanoma, Meningioma, Mullerian aplasia, myeloproliferative polycythaemia vera, neural tube defects, neuroblastoma, obesity, ovarian cancer, pheochromocytoma, pituitary adenoma, Prader-Willi syndrome, pre-eclampsia, prostate cancer, Silver-Russell syndrome, Wiedemann-Beckwith syndrome, Wilms' tumor" |
| MEG3 | NONHSAT039745 | Gtl2, ENSG00000214548 | maternally expressed 3 (non-protein coding) | glioma |
| ADAMTS9-AS2 | ADAMTS9-AS2 | N/A | ADAMTS9 antisense RNA 2 | glioma |
| CCDC26 | CCDC26 | "MGC27434, RAM" | CCDC26 long non-coding RNA | glioma |
| HCP5 | HCP5 | "D6S2650E, P5-1" | HLA complex P5 (non-protein coding) | glioma |
| MIR210HG | MIR210HG | N/A | MIR210 host gene | inflammatory renal epithelial injury |
| HOXA11-AS | NONHSAT119704 | "HOXA cluster antisense RNA 5 (non-protein coding), HOXA-AS5, ""HOXA11 antisense RNA 1 (non-protein coding)"", HOXA11-AS1, HOXA11S, NCRNA00076, ""non-protein coding RNA 76"", ENSG00000240990" | HOXA11 antisense RNA | glioma, ovarian cancer |
| DRAIC | DRAIC | N/A | "downregulated RNA in cancer, inhibitor of cell invasion and migration" | prostate cancer, bladder cancer, low-grade gliomas, lung adenocarcinoma, stomach adenocarcinoma, renal clear cell carcinoma, hepatocellular carcinoma, skin melanoma |
| LINC01198 | LINC01198 | N/A | long intergenic non-protein coding RNA 1198 | anaplastic gliomas |
